T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation. [electronic resource]
Producer: 19990805Description: 434-41 p. digitalISSN:- 0006-4971
- Adolescent
- Adult
- Biomarkers, Tumor -- blood
- Bone Marrow Transplantation -- adverse effects
- Cyclosporine -- therapeutic use
- Female
- Follow-Up Studies
- Fusion Proteins, bcr-abl -- blood
- Gastrointestinal Hemorrhage -- etiology
- Graft Enhancement, Immunologic
- Graft vs Host Disease -- mortality
- Graft vs Tumor Effect
- HLA Antigens -- immunology
- Histocompatibility
- Humans
- Immunosuppressive Agents -- therapeutic use
- Incidence
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- mortality
- Leukemia, Myeloid, Chronic-Phase -- mortality
- Leukocyte Transfusion
- Life Tables
- Lymphocyte Depletion
- Male
- Middle Aged
- Neoplasm, Residual
- Nuclear Family
- Polymerase Chain Reaction
- Salvage Therapy
- Survival Analysis
- T-Lymphocytes
- Tissue Donors
- Transplantation Conditioning
- Transplantation, Homologous
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.